Comparison of ramosetron with ondansetron for the prophylaxis of PONV after craniotomy.

Trial Profile

Comparison of ramosetron with ondansetron for the prophylaxis of PONV after craniotomy.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2017

At a glance

  • Drugs Ondansetron; Ramosetron
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 25 Mar 2013 Status changed from not yet recruiting to completed as reported by Korean Clinical Trials Register record.
    • 18 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top